科技通报
科技通報
과기통보
BULLETIN OF SCIENCE AND TECHNOLOGY
2015年
8期
27-29,250
,共4页
剖宫产%瘢痕妊娠大出血%子宫动脉栓塞术%SPSS分析
剖宮產%瘢痕妊娠大齣血%子宮動脈栓塞術%SPSS分析
부궁산%반흔임신대출혈%자궁동맥전새술%SPSS분석
cesarean section%scar pregnancy bleeding%uterine artery embolization%SPSS analysis
目的:对子宫动脉栓塞术在剖宫产后瘢痕妊娠大出血中的临床表现进行探讨.方法:将某一医院于2012年1月至2013年1月收治的30例CSP患者作为对象,以是否行UAE为依据将其分为栓塞组A以及非栓塞组B,其中栓塞组共20例,当中的15例在UAE后行清宫术,另外5例在UAE后行开腹或阴式病灶切除术.此外非栓塞组共10例,当中6例是直接行清宫术,此外2例病灶局部注射甲氨蝶呤(MTX)50 mg后行清宫术,另外2例直接开腹行病灶切除术.结果:A组治疗成功率远远高于B组,其患者的临床指标也远比B组要好,并且比较两组的造影表现和不良反应并发症,A组的安全系数要高于B组,由此可知子宫动脉栓塞术作为一种治疗手段,其安全性较强,因此值得临床推广.
目的:對子宮動脈栓塞術在剖宮產後瘢痕妊娠大齣血中的臨床錶現進行探討.方法:將某一醫院于2012年1月至2013年1月收治的30例CSP患者作為對象,以是否行UAE為依據將其分為栓塞組A以及非栓塞組B,其中栓塞組共20例,噹中的15例在UAE後行清宮術,另外5例在UAE後行開腹或陰式病竈切除術.此外非栓塞組共10例,噹中6例是直接行清宮術,此外2例病竈跼部註射甲氨蝶呤(MTX)50 mg後行清宮術,另外2例直接開腹行病竈切除術.結果:A組治療成功率遠遠高于B組,其患者的臨床指標也遠比B組要好,併且比較兩組的造影錶現和不良反應併髮癥,A組的安全繫數要高于B組,由此可知子宮動脈栓塞術作為一種治療手段,其安全性較彊,因此值得臨床推廣.
목적:대자궁동맥전새술재부궁산후반흔임신대출혈중적림상표현진행탐토.방법:장모일의원우2012년1월지2013년1월수치적30례CSP환자작위대상,이시부행UAE위의거장기분위전새조A이급비전새조B,기중전새조공20례,당중적15례재UAE후행청궁술,령외5례재UAE후행개복혹음식병조절제술.차외비전새조공10례,당중6례시직접행청궁술,차외2례병조국부주사갑안접령(MTX)50 mg후행청궁술,령외2례직접개복행병조절제술.결과:A조치료성공솔원원고우B조,기환자적림상지표야원비B조요호,병차비교량조적조영표현화불량반응병발증,A조적안전계수요고우B조,유차가지자궁동맥전새술작위일충치료수단,기안전성교강,인차치득림상추엄.
Objective:To investigate the clinical manifestations of uterine artery embolization after cesarean scar pregnancy bleeding in. Methods:CSP patient in a hospital from January 2012 to January 2013 a total of 30 cases were treated as ob-jects, divided according to whether the line UAE embolization group A and non-embolization group B, embolization group of 20 cases, 15 cases underwent in UAE curettage, five cases in the UAE underwent laparotomy or vaginal lesion resection. Non-embolization group of 10 cases, including six cases of direct curettage, two cases of lesions local injection of metho-trexate (MTX) 50 mg underwent curettage, two cases of direct open line lesion resection. Results:A group treatment suc-cess rate is much higher than group B, patients with clinical indicators which are better than group B, and complications, the safety factor of group A were compared and contrast the performance of adverse reactions higher than group B, proof of uterine artery embolization is a safe and effective treatment, worthy of promotion.